Generics News

Generics News

Teva Launches Generic Atelvia

Teva announced the launch of Risedronate Sodium Delayed-Release Tablets, the generic version of Warner Chilcott's Atelvia.

Mylan Launches Generic Seasonale

Mylan announced the launch of Levonorgestrel and Ethinyl Estradiol Tablets, the generic version of Teva's Seasonale.

Teva Launches New Generic FazaClo Strengths

Teva announced the launch of two new strengths of Clozapine ODT (orally disintegrating tablets), the generic version of Jazz Pharmaceutical's FazaClo.

Breckenridge Approved for Generic Prandin

Breckenridge announced it has received final approval by the Food and Drug Administration (FDA) for Repaglinide Tablets, the generic version of Novo Nordisk's Prandin.

Teva Launches Argatroban Injection

Teva announced the launch of Argatroban Injection in 0.9 percent Sodium Chloride.

Antipsychotic Agent Gets First Generic Approval

The Food and Drug Administration has approved Aripiprazole, the first generic version of Otsuka's Abilify.

Perrigo Launches Generic Kenalog Spray

Perrigo announced the launch of Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma's Kenalog spray.

First Generic Version of Copaxone Now Approved

The Food and Drug Administration (FDA) has approved Sandoz's Glatiramer Acetate Injection, the first generic version of Teva's Copaxone.

Generic Exalgo Coming Soon from Perrigo

Perrigo announced that it has received final approval from the Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Hydromorphone HCI Extended-Release Tablets, the generic version of Mallinckrodt's Exalgo.

First Generic Version of Generess Fe Launched

Mylan announced the launch of Norethindrone and Ethinyl Estradiol Tablets 0.8mg/0.025mg and Ferrous Fumarate Tablets 75mg, the generic version of Warner Chilcott's Generess Fe.